-

Asahi Kasei Starts Selling BR and S-SBR Made Using the Mass-balance Method

— Toward achievement of sustainability —

NEW YORK & DÜSSELDORF, Germany & TOKYO--(BUSINESS WIRE)--Asahi Kasei, a diversified Japanese multinational company, will begin the sale of Tufdene™ S-SBR (solution-polymerized styrene-butadiene rubber) and Asadene™ BR (butadiene rubber) made using the mass-balance method1 at Asahi Kasei Synthetic Rubber Singapore Pte. Ltd. and the Synthetic Rubber Plant of Asahi Kasei's Kawasaki Works in November 2022. The sale will be based on the ISCC PLUS2 certification for S-SBR and BR acquired by Asahi Kasei's Synthetic Rubber Division in October 2022.

Asahi Kasei has gained a strong reputation for its high-performance grades of S-SBR that are optimal for eco-friendly tires with excellent fuel efficiency and wear resistance characteristics. In order to further contribute to reduced CO2 emissions, Asahi Kasei will manufacture and sell S-SBR made using the mass-balance method with raw material derived from biomass and plastic waste along with other raw material.

There is also growing demand for reduced environmental burden in various other applications, including requests to decarbonize. For these applications, Asahi Kasei will similarly manufacture and sell BR made using the mass-balance method.

Asahi Kasei aims to be a sustainable partner for its customers through the manufacture and sale of these products, while reducing GHG emissions from manufacturing at each plant and contributing to reduced burden on the global environment.

1 In the case of a mixture of sustainable raw materials and fossil fuel-derived raw materials in the production process, the portion of sustainable product produced is assigned to certain products based on ISCC PLUS System Documents and its recognized management methods.

2 ISCC (International Sustainability and Carbon Certificate) is an international certification system that offers solutions for the implementation and certification of waste and residue raw materials, non-bio renewables and recycled carbon materials and fuels. ISCC PLUS is a certification system that covers mainly bio-based carbon materials which are produced outside of the EU and supplied globally, and to manage and ensure sustainable raw materials in the supply chain.

About Asahi Kasei

The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 46,000 employees around the world, the company contributes to a sustainable society by providing solutions to the world's challenges through its three business sectors of Material, Homes, and Health Care. Its Materials sector, comprised of Environmental Solutions, Mobility & Industrial, and Life Innovation, includes a wide array of products from battery separators and biodegradable textiles to engineering plastics and sound solutions. For more information, visit https://www.asahi-kasei.com/.

Asahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon-neutral society by 2050. To learn more, visit https://www.asahi-kasei.com/sustainability/.

Contacts

Company North America:
Asahi Kasei America, Inc.
Jon Todd
39475 W. Thirteen Mile Road, Suite 201, Novi, MI 48377
E-mail: AKA-info@ak-america.com

Company Europe:
Asahi Kasei Europe GmbH
Sebastian Schmidt
Fringsstrasse 17, 40221 Düsseldorf
Tel: +49 (0) 211-3399-2058
E-mail: sebastian.schmidt@asahi-kasei.eu

Asahi Kasei Group

TOKYO:3407

Release Versions

Contacts

Company North America:
Asahi Kasei America, Inc.
Jon Todd
39475 W. Thirteen Mile Road, Suite 201, Novi, MI 48377
E-mail: AKA-info@ak-america.com

Company Europe:
Asahi Kasei Europe GmbH
Sebastian Schmidt
Fringsstrasse 17, 40221 Düsseldorf
Tel: +49 (0) 211-3399-2058
E-mail: sebastian.schmidt@asahi-kasei.eu

Social Media Profiles
More News From Asahi Kasei Group

Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults

TOKYO--(BUSINESS WIRE)--Asahi Kasei Therapeutics, Inc., the global specialty pharmaceutical business of Tokyo-based Asahi Kasei, with U.S. and European business headquarters in Cary, North Carolina, today announced that the U.S. Food and Drug Administration (FDA) has approved HOVILPRI® (pritelivir) 100 mg tablets for the treatment of mucocutaneous lesions caused by herpes simplex virus (HSV) infection that is refractory (with or without documented resistance) to treatment with acyclovir, valacy...

Asahi Kasei Microdevices Holds IEEE Milestone Commemoration Ceremony in Nobeoka for the Commercialization of Thin-Film Hall Elements

TOKYO--(BUSINESS WIRE)--Asahi Kasei Microdevices held a ceremony to celebrate the recognition of the 1983 commercialization of thin-film Hall elements as an IEEE Milestone....

Asahi Kasei Therapeutics Announces First Patient Dosed in Phase 2a Trial of AIC468 for BK Virus Infection in Kidney Transplant Recipients

TOKYO--(BUSINESS WIRE)--Asahi Kasei Therapeutics announced that the first patient has been dosed in a randomized Phase 2a clinical trial (NCT07503561) evaluating AIC468....
Back to Newsroom